Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04380389 · ClinicalTrials.gov registry record · NA
Accuracy of ScanWatch Pulse Oximeter With Profound Hypoxia
A NA study, sponsored by Withings.
- Completed
- Registry status
- NA
- Development phase
- 14
- Enrollment target
NCT04380389 is a NA study that has completed, run by Withings. The registered enrollment target is 14 participants.
The verdict
NCT04380389, a NA study, has completed, sponsored by Withings.
- COMPLETED
- Registry status
- NA
- Development phase
- 14 participants
- Enrollment target
Study Summary
Performance testing of pulse oximeters. The protocol involves brief stable arterial oxygen desaturation in healthy volunteers and sampling arterial blood when a stable level of hypoxia has been attained. The blood sample is analyzed for oxygen saturation with a gold standard bench CO-oximeter. This protocol is aligned with the latest ISO and FDA guidance documents for pulse oximeter testing.
Interventions
- DIAGNOSTIC_TEST hypoxia
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 14 participants |
| Start Date | 2020-03-11 |
| Est. Completion | 2020-03-12 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04380389
The ClinicalTrials.gov registry entry for NCT04380389 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 14 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Withings, which has 5 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which hypoxia is the first listed.
NCT04380389 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT04380389 about?
NCT04380389 is a clinical study titled "Accuracy of ScanWatch Pulse Oximeter With Profound Hypoxia". Performance testing of pulse oximeters. The protocol involves brief stable arterial oxygen desaturation in healthy volunteers and sampling arterial blood when a stable level of hypoxia has been attained. The blood sample is analyzed for oxygen saturation with a gold standard bench CO-oximeter. This ...
What is the current status of trial NCT04380389?
This trial is currently completed. It is a NA study. The enrollment target is 14 participants. The study started on 2020-03-11. Estimated completion is 2020-03-12.
What interventions are being tested in trial NCT04380389?
The interventions under investigation include: hypoxia (DIAGNOSTIC_TEST).
Who is sponsoring clinical trial NCT04380389?
This trial is sponsored by Withings, which has 5 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.